Real-world insights into non-small cell lung cancer patients with MET exon 14 skipping mutations: A Swedish retrospective study from two university hospitals

被引：0
|
作者：
Skribek, M. [1 ]
Brunnstrom, H. [2 ]
Aricak, O. [3 ]
Planck, M. [4 ]
Jatta, K. [5 ]
Oskarsdottir, G. N. [4 ]
Naserhojati, H. [6 ]
Haglund, F. [7 ]
Ekman, S. [8 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Lund Univ, Div Pathol, Lund, Sweden
[3] Karolinska Univ Hosp, Dept Pathol & Cytol, Solna, Sweden
[4] Lund Univ, Div Oncol, Lund, Sweden
[5] Karolinska Univ Hosp Solna, Dept Pathol & Cytol, Solna, Sweden
[6] Karolinska Univ Hosp, Dept Pathol & Cytol, Huddinge, Sweden
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Karolinska Inst, Dept Oncol Pathol, Solna, Sweden
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1302
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1179P
引用
收藏
页码：S1087 / S1087
页数：1
相关论文
共 50 条
  • [31] Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer with MET Exon 14 Skipping
    Han, Y.
    Chen, S.
    Xiang, C.
    Guo, L.
    Zhu, L.
    Shao, J.
    Hu, T.
    Wang, J.
    Zhu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S60 - S61
  • [32] Identification of a Novel MET Exon 14 Skipping Variant in Non-Small Cell Lung Cancer
    Cheng, Y.
    Das, R.
    Jakubowski, M.
    Spildener, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S89 - S89
  • [33] Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)
    Illini, O.
    Fabikan, H.
    Swalduz, A.
    Krenbek, D.
    Vikstrom, A.
    Schumacher, M.
    Dudnik, E.
    Studnicka, M.
    Ohman, R.
    Wurm, R.
    Wannesson, L.
    Peled, N.
    Kian, W.
    Bar, J.
    Daher, S.
    Addeo, A.
    Rotem, O.
    Pall, G.
    Zer, A.
    Saad, A.
    Cufer, T.
    Sorotsky, H. G.
    Hashemi, S. M. S.
    Mohorcic, K.
    Stoff, R.
    Rovitsky, Y.
    Keren-Rosenberg, S.
    Winder, T.
    Weinlinger, C.
    Valipour, A.
    Hochmair, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S460 - S460
  • [34] Antitumor effects of ensartinib in non-small cell lung cancer harboring MET exon 14-skipping mutations
    Xia, Yang
    Lan, Fen
    Zhao, Jing
    Shen, Hua-Hao
    Selvaggi, Giovanni
    Li, Wen
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib
    Paik, Paul K.
    Goyal, Ravi K.
    Cai, Beilei
    Price, Mark A.
    Davis, Keith L.
    Ansquer, Valerie Derrien
    Caro, Nydia
    Saliba, Teddy R.
    FUTURE ONCOLOGY, 2023, 19 (03) : 217 - 228
  • [36] Real-world next-generation sequencing (NGS) and treatment (Tx) patterns in non-small cell lung cancer (NSCLC) patients (pts) with MET exon 14 skipping mutations (METex14)
    Le, X.
    Martinalbo, J.
    Holynskyj, A.
    Rhodes, W. C.
    Wu, W-H.
    Kim, J.
    Pretre, V.
    Ye, F.
    Morrissette, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S988 - S988
  • [37] Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping
    Hur, Joon Young
    Ku, Bo Mi
    Shim, Joon Ho
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    IN VIVO, 2020, 34 (03): : 1399 - 1406
  • [38] Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients.
    Zhang, Baihua
    Xia, Yu
    Zhang, Jiujin
    Yu, Jin
    Chen, Min
    Yao, Wei
    Zhao, Juan
    He, Jiqiang
    Mok, Tony S. K.
    Wang, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer
    Ahn, Linda
    Alexander, Terri
    Vlassak, Soetkin
    Berghoff, Karin
    Lemmens, Liesbeth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (05) : 543 - 551
  • [40] Immunotherapy for stage IV non-small cell lung cancer patients with MET exon 14 skipping mutation
    Kuon, J.
    Blasi, M.
    Shah, R.
    Christopoulos, P.
    Stenzinger, A.
    Kazdal, D.
    Herth, F. J.
    Heussel, C. P.
    Thomas, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 172 - 172
12345